scholarly journals Maternal Fetal Simulator

2020 ◽  
Vol 3 (1) ◽  
pp. 5-9
Author(s):  
MARCELO ANTUNES MARCIANO ◽  
Rodrigo Rezer ◽  
Anderson Santos

In this study it is presented the implementation of a low-cost automated prototype, in an open code platform, that simulates maternal fetal signals, allowing test executions and fetal detectors. The goal is guaranteeing the use of these equipments in a safe, effective way in the monitoring of maternal fetal signals in hospital environments, since the simulator is used to evaluate the correct use of the equipment. Another possible application of the simulator is as a teaching tool. The results are demonstrated in a man-machine interface, the views of the measurements of fetal movement, uterine activity and fetal heart rate, generated by the simulator. The values demonstrated in the man-machine interface can be compared with the ones presented by the fetal monitor. With this comparison it is possible to check the correct functioning of the equipment tested.

1976 ◽  
Vol 126 (1) ◽  
pp. 61-69 ◽  
Author(s):  
H.E. Fox ◽  
M. Steinbrecher ◽  
B. Ripton

2014 ◽  
Vol 24 (6) ◽  
pp. 3763-3769 ◽  
Author(s):  
Yaosheng Lu ◽  
Xiaodong Li ◽  
Shouyi Wei ◽  
Xiaolei Liu

2015 ◽  
Vol 43 (4) ◽  
Author(s):  
Nele Everaert ◽  
Marc Coppens ◽  
Peter Vlerick ◽  
Geert Braems ◽  
Patrick Wouters ◽  
...  

AbstractWe retrospectively compared a protocol using sufentanil and ropivacaine intrathecally with a protocol in which only ropivacaine was administered intrathecally and sufentanil was used epidurally to evaluate whether banning sufentanil from the intrathecal space results in a decreased incidence of adverse fetal heart rate changes.Some 520 cardiotocographic tracings were examined for changes in fetal heart rate and uterine activity following two different protocols of combined spinal epidural analgesia. Charts were consulted for neonatal and labor outcome.When sufentanil was used epidurally instead of intrathecally, the incidence of adverse changes in fetal heart trace was less, demonstrated by a higher percentage of normal reassuring tracings (74.5% vs. 60.4% when sufentanil was used intrathecally; P=0.007), less tracings showing bradycardia (7.5% vs. 14.1%; P=0.035), and more tracings displaying 3 or more accelerations in fetal heart rate in 45 min (93.5% vs. 83.9%; P=0.003) together with less episodes of tachycardia (3.5% vs. 11.4%; P=0.005). There were no differences in labor and neonatal outcome.Based on fetal heart tracing, it seems favorable to ban sufentanil from the intrathecal compartment.


2002 ◽  
Vol 22 (4) ◽  
pp. 333-335
Author(s):  
Martin L Gimovsky ◽  
Gene Freylikhman ◽  
Kenneth A Kappy

Sign in / Sign up

Export Citation Format

Share Document